Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 28.35-21.6327.368.439.27

What is the latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS is 28.35 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202528.35
Mar2024-21.63
Mar202327.36
Mar20228.43
Mar20219.27

How is Price to Cash Earnings (PCE) of GLENMARK PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 28.35
Positive
Mar2024 -21.63
Negative
Mar2023 27.36
224.56
Mar2022 8.43
-9.06
Mar2021 9.27 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,251.5 Cr -0.5% 5.3% 43.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.5%

5.3%

43.5%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses